UAE’s Yas Clinic partners with Ohio University to advance cell and gene therapy research

Yas Clinic Khalifa City and the Abu Dhabi Stem Cells Center (ADSCC) have signed a strategic Memorandum of Understanding (MoU) with Ohio University to advance research and innovation in cellular and gene therapies.

The agreement positions Abu Dhabi as a growing hub for cutting-edge medical science and global collaboration, according to a WAM report.

The signing ceremony coincided with a scientific exchange event that gathered international researchers, clinicians, and medical leaders to discuss stem cell innovation, emerging cellular therapies, and new clinical applications with potential to transform patient care. Sessions highlighted ADSCC’s stem cell programs, global advances in cell and gene therapies, and therapeutic developments beyond oncology.

The collaboration seeks to strengthen international research networks, facilitate knowledge exchange, and support the development of innovative treatments in hematology, oncology, and regenerative medicine. It underscores Abu Dhabi’s commitment to integrating scientific research with practical healthcare solutions.

Dr. Maysoon Al Karam, Chief Medical Officer at Yas Clinic – Khalifa City, said: “This partnership reflects our goal of turning research into real-world impact. Working with ADSCC and Ohio University expands our academic and clinical ecosystem and accelerates innovation in cellular and gene therapies for the benefit of patients worldwide.”

The event also showcased advancements in CAR-T and other cellular therapies, emphasizing the need for global collaboration, local clinical application, and faster translation of research into treatment.

Mubasher Maqbul, Acting CEO of Yas Clinic, added: “Our collaboration strengthens pathways for scientific discovery and innovation, bringing advanced therapies closer to patients and fostering international research partnerships.”

Dr. Mohamed Abuhaleeqa, Consultant in Hematology & Bone Marrow Transplant and Chair of Academic Affairs at Yas Clinic – Khalifa City, noted: “Strategic research partnerships are essential for modern medicine. This alliance promotes clinical learning, scientific exchange, and translational research, accelerating the development of next-generation therapies and improving outcomes regionally and globally.”

The MoU highlights a shared vision among Yas Clinic, ADSCC, and Ohio University to foster sustainable academic partnerships, drive clinical innovation, and contribute to the worldwide advancement of regenerative and precision medicine.